The Centre for Trials Research (CTR), Cardiff University is delighted to be working in partnership with the Health Research Board -Trials Methodology Research Network (HRB-TMRN) in Ireland, to launch the new Trial Governance Placement Scheme from March 2023. This is a fantastic opportunity for the CTR to forge a collaboration with international colleagues and to share
Trial Governance Placement Scheme launch: March 2023 Read More »
Written by Prof Shaun Treweek – Trial Forge, University of Aberdeen In 2022 we published an article called ‘Getting it wrong most of the time? Comparing trialists’ choice of primary outcome with what patients and health professionals want‘. It looked at the outcomes selected in 44 breast cancer and kidney trials and asked patients and
Need to do better at involving patients and public in trial outcome selection Read More »
HRB invests €7 million to nurture a talented new generation of academic researchers Health inequality, schizophrenia, and therapies in children with cystic fibrosis are three of nine important topics to be addressed by our Emerging Investigator Awards for Health (EIA) 2022. Dr Karen Matvienko-Sikar based in UCC and a HRB-TMRN Research Associate secured funding for
Date: 09 October 2020 Publication of the results of the 100th JLA research Priority Setting Partnership (PSP) provides an opportunity for me to look back on my involvement with the James Lind Alliance since 2008. In thinking about this very special initiative, I was grateful that Iain Chalmers – who had lobbied for the creation of
100 JLA PSPs: A chance to reflect Read More »
By Prof Shaun Treweek & Colleagues – We do randomised trials to improve healthcare decisions, decisions that may have a lasting influence on people’s health. Every day the public, patients, healthcare professionals and policymakers make decisions about healthcare, their own or that of others. Randomised trials can help to make those decisions more informed. [Read
Jeremy Taylor, NIHR Director for Public Voice, NIHR Centre for Engagement and Dissemination, discusses how COVID-19 has brought clinical trials to the forefront and outlines recent work done by the Centre on improving the experience of those participating in clinical trials. Suddenly everyone is talking about clinical trials. COVID-19 has raised their public profile and
Improving clinical trials: Keep the focus on the participants Read More »
Date: 24 March 2020 By Derek Stewart – Patient Representative & MRC-NIHR-TMRP PPI Lead Trials Methodology Research (1) is about looking at the way health research is carried out – i.e. improving the tools and trade of research practice. It is carried out by researchers often referred to as Methodologists. These types of studies differ from doing
What is Trials Methodology Research – a patient’s viewpoint. Read More »
Date: 17 Ocober 2019 By Andrew Worrall – Patient Partner with the PRioRiTy II research study Members of the HSRU team attended the International Clinical Trials Methodology Conference (ICTMC) in Brighton last week. It was a fantastic conference with ubiquitous examples of world leading methodological research being presented. Three of the HSRU team in attendance
Date: 28 May 2019 By Sarah Chapman – Knowledge Broker – Cochrane UK School children in Ireland have run and presented their own randomised trials in the innovative START competition. Here’s what they achieved and why this matters. If you’ve ever taken part in a clinical trial, I hope you were told very clearly what
Children can do randomised trials – START competition 2019 Read More »
Date: 12 March 2019 By Dr Heidi Gardner #trialretention Randomised clinical trials are the gold standard method for gathering evidence about health and care interventions. That said, randomised trials are not perfect, and many of them run into issues through the process of trial design and delivery. Participants are central to the successful completion of trials;